02.17.21

Eyevance’s Natacyn Now Available for Next-Day Delivery

Source: Eyevance Pharmaceuticals

03.30.20

Eyevance Pharmaceuticals Launches Zerviate in the United States

Source: Eyevance Pharmaceuticals

03.02.20

Eyevance Pharmaceuticals launches Tobradex ST in the United States

Source: Eyevance Pharmaceuticals

02.24.20

Eyevance Pharmaceuticals Appoints Julie Speed as Chief Commercial Officer

Source: Eyevance Pharmaceuticals

10.16.19

Eyevance Pharmaceuticals Acquires Tobradex ST and Natacyn

Source: Eyevance Pharmaceuticals

07.09.19

Nicox Receives $3 Million Milestone Payment From Eyevance for Zerviate in the US

Source: Nicox

10.24.18

Eyevance Pharmaceuticals Acquires Exclusive Rights to Commercialize Flarex in the United States

Source: Eyevance Pharmaceuticals

10.02.18

Eyevance Acquires Global Rights to Persistent Corneal Epithelial Defect Treatment Nexagon

Source: Eyevance Pharmaceuticals

View more stories